Contact Us

News

  • Hon’ble delegation member of CII

    Managing Director Mr. Alok Kumar – Hon’ble delegation member of CII delegation to Minsk Belarus 24th Sept 2018, announced upcoming investment and business with Belarus.

    2018-09-27 14:45:29

  • Onco plant at Goa

    Onco plant at Goa -internal and external infra works are in full swing target to operational by 4th quarter of 2018

    2018-09-27 14:47:06

  • Managing Director Mr. Alok Kumar

    Managing Director Mr. Alok Kumar - Invitee guest during opening of Belarus Consulate at Mumbai

    2018-09-27 14:48:13

  • Plant 1 OSD , 4 Dept

    Plant 1 OSD , 4 Dept, Atgaon, Thane ,India - Russian GMP, Belarus GMP and PIC/s Certified.

    2018-09-27 14:48:45

  • Domestic Market

    3 new products are schedule to launch for Anti fungal, Laxative and Respiratory

    2018-12-04 10:37:57

  • Message 1

    7-Mar-2019 10:00 AM: Opening Ceremony of Novalok LLC (Oral Solid Dose Plant) at Belarus, 31761, Grodno District, SKidel, st. Kizevich 50

    2019-03-07 13:43:05

Quote

  • Competition makes things come out right. Well, what does that mean in health care? More hospitals so they compete with each other. More doctors compete with each other. More pharmaceutical companies. We set up war. Wait a minute, let's talk about the patient. The patient doesn't need a war.
    Donald Berwick

RND & ADL ATGAON THANE
  • Lok-Beta has independent Research & Development facility for Development new formulation in different segment of niche molecules equipped with well qualified personnel supported by latest technology and machine. Spread over separate 650 Sq. M. block.
  • Lok-Beta is currently investing heavily in the research and development of new Pharmaceutical & Healthcare formulations. The next few years will see a stream of new Lok-Beta products being established in the market.
  • Research & Development is a major component for pharmaceutical products. Spectrums of research are carried out in our Company ranging from development of new applications for existing products to upgrade of formulations efficiency and improving drug delivery systems.
  • Lok-Beta niche molecules such as Antiretroviral, Immunosuppressant, Urological, Antihypertensive, Anti diabetics and Anti Tuberculosis are aim is to provide /develop new formulation and application for the human well-being.
  • Lok-Beta developed more than 40 Niche molecules and rigorously planning for develop @10 new core products yearly